AMR in the Light of COVID-19 Webinar Series Please join us on Nov 19 for the last webinar in the free "AMR in the Light of COVID-19" series. We're looking forward to a fascinating discussion on "Responding to difficult-to-treat infections: Role and responsibilities of governments, researchers, industry and patients," among James Anderson, MBA, MA, Michael Craig, MPP, Nana Kuo, MSc, Mirfin Mpundu, BPharm, MPH, MBA, and Kathy Talkington, MPA. Jeremy Knox, MSc, will moderate the conversation. The webinar series is brought to you by the Antimicrobial Resistance (AMR) Fighter Coalition, in partnership with CIDRAP, the American Society for Microbiology, Wellcome, the Surveillance and Epidemiology of Drug-resistant Infections Consortium, and the US Centers for Disease Control and Prevention. Register View past webinars | | | | | | AMR and AMS in the News This week, CIDRAP News reported on an algorithm to improve antibiotic prescribing for urinary tract infections and much more. | | | Quiz on US AMR Governance Test your knowledge on US national plans and activities to help prevent the emergence of antibiotic-resistant bacteria. | | | | | | | Impact of AMR on Cancer Care The Union for International Cancer Control will host a dialogue on the need to prioritize cancer care in discussions about AMR. | | | Neglected Tropical Diseases The World Health Organization will host a webinar on the need to include neglected tropical diseases in One Health AMR activities. | | | COVID-19 and Antimicrobial Stewardship | | UK Communications Toolkit In observance of World Antibiotic Awareness Week and European Antibiotic Awarenesss Day, Public Health England published a "Resources toolkit for healthcare professionals in England in the context of the COVID-19 pandemic." | | COVID-19 and Sepsis A University of Manchester press release describes the adaptation of the ADAPT-Sepsis study to include seriously ill COVID-19 patients in the work to increase effectiveness of antibiotic prescribing for patients with suspected sepsis. | | Respiratory Tract Infection Toolkit Choosing Wisely Canada released a new edition of the Cold Standard Toolkit, which provides three clinical tools to support the virtual and in-person management of respiratory tract infections during the COVID-19 pandemic. | | Diagnostic for COVID-19 and Ventilator-Associated Pneumonia On The Conversation, Lara Marks, DPhil, and Andrew Morris, MBChB, PhD, discuss the use of a rapid diagnostic test for patients with COVID-19 and suspected ventilator-associated pneumonia in a UK intensive care unit. | | Pneumonia Panel for COVID-19 Patients In Contagion, Molly M. Miller, PharmD, et al describe the experience of implementing a polymerase chain reaction pneumonia panel at Nebraska Medicine during the COVID-19 pandemic. | | Antibiotic R&D Incentives In a webinar hosted by European Health Forum Gastein and organized by MSD, Jacki Davis moderates a discussion on "AMR and COVID-19: How can Europe incentivise R&D to protect our future?" | | | | Global AMR/AMS Policy and Projects | | UK OPAT Investment Recommendations The UK Department of Health and Social Care released a report recommending investment in hubs to produce aseptic injectable medicines in England, which has the potential to improve the provision of outpatient parenteral antibiotic therapy. | | Drug-Resistant Gonorrhea in South Africa On The Conversation, Remco Peters, MD, PhD, MSc, and Liteboho Daniel Maduna, PhD, MSc, discuss a recent study of drug resistance in Neisseria gonorrhoeae among high-risk men in South Africa, highlighting what the study revealed about the importance of investing in country-wide antimicrobial resistance surveillance programs that include high-risk populations. | | UK Environmental AMR Framework The UK government issued a framework for understanding environmental AMR in England, summarizing the quality of the data and its usefulness for policy decisions. | | AMR and Antimicrobial Use in Northern Ireland The Northern Ireland Public Health Agency released a report on antimicrobial use and AMR during 2018. | | | | | | | | COVID-19 and Co-infections in Germany In the European Journal of Clinical Microbiology, Kathrin Rothe, Dr. Med, et al evaluate 140 COVID-19 patients admitted to a German hospital from February to April 2020, finding that, among 50 patients admitted to intensive care units, 34% were co-infected with Enterobacterales species, and 18% had Aspergillus fumigatus co-infections. | | | ICHE Open-Access Conference Abstracts Infection Control and Hospital Epidemiology published an open-access supplement, which includes poster presentations and extensive abstracts on antimicrobial stewardship, COVID-19, and infection control research from the canceled Sixth Decennial International Conference on Healthcare-Associated Infection. | | | | | |
No comments:
Post a Comment